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Senior Honors Project Reflection Essay 
Molly Brennan 
 The development of my Senior Honors Project has been both a trying and tremendously 
rewarding experience. Over the course of this project, I have been able to investigate a topic that 
is near and dear to my heart, and to create a product that I hope will impact many nurses and 
patients in the future. My Senior Honors Project is focused on the nursing implications of bath 
salts abuse. The management of bath salts abuse has been both a challenge and a gray area within 
the healthcare system in recent years, and has affected me directly within my practice.  
 During December of 2011, while working as an Emergency Medical Technician in 
northern Virginia, I was dispatched on a call that opened my eyes to the challenges presented by 
drugs of abuse. In 30-degree weather, I found my patient naked in the middle of a busy highway 
intersection, crawling on all fours, growling at passing vehicles. Her words were 
incomprehensible, and she was extremely combative towards myself, my crew, and the law 
enforcement personnel on scene. This woman’s skin was also notably hot to the touch. Upon our 
arrival at the nearest Emergency Department, I noted a visible deflation in the department staff’s 
demeanor. I observed a lack of clarity among the staff about how to care for this woman, or what 
could possibly be wrong with her. Upon leaving the department, the patient was in restraints, 
accompanied by two security officers, and was still thrashing about and growling. Although I 
have wondered since that day, I will never know what happened to her.  
 Three months later, while completing my Mental Health Nursing clinical rotation at 
Rockingham Memorial Hospital, I had the privilege of sitting in on a continuing education 
presentation for hospital nurses and physicians. The presentation was given by representatives of 
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a local agency, which specializes in the rehabilitation of bath salts abuse patients. During this 
presentation, I had a bit of an “aha” moment.  Although I of course could not be sure, I felt that I 
could finally understand what had happened to my growling, naked patient three months earlier. 
I was immediately interested in this topic, and the dangers of this drug to an individual’s physical 
and mental health.  Conveniently, this occurred at about the time I was trying to develop an idea 
for my Senior Honor’s Thesis.  
 In May of 2013, I submitted my Senior Honor’s Project Proposal, with the full intention 
of completing a systematic review of the literature. This review was anticipated to cover the 
acute, chronic, and community health implications of bath salts abuse for nurses. I realized 
quickly when beginning my research that all three topics would be far too much information for 
one well-written review to cover. For this reason, I decided to narrow my research to focus on 
the acute implications of bath salts abuse. I continued in this research throughout the fall of 2013, 
scouring research databases, and developing the bones of my paper and the point I would be 
trying to make.  
 During the early spring of this year, my plans for the project changed dramatically. The 
development of my paper was lacking, as well as my motivation. I found myself toying with the 
idea of withdrawing from Honors 499C, as I felt that I did not have adequate time to put into the 
development of a quality research paper. However, my faculty advisor and the Nursing Honor’s 
Liaison presented me with other options regarding the final product of my project. Although 
discontinuing the project was on my mind, I had invested so much of my time and heart into 
research and the initial development of my paper that I was eager to learn of other options.  I 
ultimately chose to transform my original plan for a systematic literature review into a learning 
tool and curriculum for Emergency Department nurses. This tool would take the shape of an 
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informative pamphlet, accompanied by a PowerPoint presentation to supplement learning. The 
learning materials that I have created are based on the information I obtained and collaborated 
through extensive research. My goal is to distribute my materials to local Emergency Department 
clinical educators in the coming weeks, and for these tools to aid them in teaching their nurses 
about the implications of bath salts abuse on their practice.  I also will be presenting my 
materials to the nurses at Arbor House, a crisis intervention program for psychiatric illness 
patients.  
Although the number of bath salts abuse cases is on the decline, the problem persists that 
Emergency Department staff members of many hospitals are unknowledgeable about the 
presentation and recommended care of these patients. Media coverage of cases of bath salts 
abuse appears far less often than it has in recent years, however patients continue to present to 
Emergency Departments and other clinical facilities for this problem. Nurses are in need of an 
understanding of how to care for these patients, and I am excited to be able to provide this 
learning tool to even a small fraction of them.  
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What are ‘Bath Salts’?
• A drug comprised of  a mixture of  man-made 
“synthetic cathinones” as well as a multitude of  
other chemicals. 
• The most common synthetic cathinones found in 
bath salts are mephedrone and 
methylenedioxypyrovalerone (MDPV). 
• These chemicals are similar in makeup to MDMA, 
Ecstasy, and amphetamines. 
 
 
Slide 3 
What are ‘Bath Salts’?
• Stimulate release of  norepinepherine, serotonin, and 
dopamine, as well as block reuptake 
• Alter the characteristics of  serotonin
• Cause psychoactive effects
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What are ‘Bath Salts’?
• Produce a stimulant effect - similar to a combination 
of LSD, cocaine, and heroine
• Have a lasting effect on the body and the brain, 
unlike LSD, cocaine, or heroine
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History of  ‘Bath Salts’ 
Production
• Synthetic cathinones are derived from the properties 
of khat, a naturally occurring stimulant
• Leaves of  khat plant are chewed customarily in 
Eastern Africa and the Arabian Penninsula
• Production originated in Israel, where cathinone
“Hagigat” first appeared in the early 2000s
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History of  ‘Bath Salts’ Use
• First evidence of  usage in the U.S. in 2007
• First clinical reports of  synthetic cathinone use as 
drugs of  abuse appeared in 2008, with a dramatic 
increase in 2009
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Slide 7 
Legality of  ‘Bath Salts’
• Orignially legal and marketed as “safe” 
• By April 2011, all states within the U.S. placed a ban on 
bath salts use and sale 
• In July 2012, President Obama signed a bill that  banned 
bath salts and all derivatives of  bath salts 
• Even so, bath salts are still available throughout the U.S., 
Europe, and the Internet
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Trends of  ‘Bath Salt’ Use
• Originally were sold legally in head shops, smoke shops, 
and gas stations under the names “bath salts”, “plant 
food”, and others 
• Common street names include Super Coke, Ivory Wave, 
White Lightning, and others 
• Sold in small packages labeled “not for human 
consumption” which contain a fine white or off-white 
powder 
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Trends of  ‘Bath Salt’ Use
• In 2009, U.S. Poison Control Centers received no calls 
about bath salts intoxication
• In 2010, there were 304 calls across the country
• In 2011, this number increased to 6,138
• The number of  calls decreased from 2011 to 2012  with the 
enactment of  legislation
(The number of calls to Poison Control is only an indication of use patterns, 
and does not necessarily represent the total number of cases of use)
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Trends of  ‘Bath Salt’ Use
• Typical user is male between ages of  20-29 with history of  
substance abuse or psychological illness 
• Accidental intoxication in children under the age of  12, 
16% of these were life-threatening
• Neonatal withdrawal reported in the infants of  women 
who consumed the drug while pregnant
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Trends of  ‘Bath Salt’ Use
• Bath salts are often used with other drugs (tobacco, 
alcohol, cannabis, cocaine) complicating effects and 
diagnosis
• Users report drug to be “addictive” despite reports of  
unwanted effects
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Routes of  Administration
• Insufflation (“snorting”)
• IV injection
• IM injection
• Ingestion
• Rectal
• In a study of 35 cases of  BSA evaluated by the Michigan 
Department of  Community Health, there was no 
correlation between route of administration and the 
severity of resulting illness 
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Slide 13 
Signs and Symptoms (S/S) of  
BSA
Psychological S/S
• Paranoia
• Insomnia
• Hallucinations
• Memory Loss
• Delusions
• Fear of  nonexistent threats to 
self
• Combativeness
• Severe Agitation
Physiological S/S
• Sweating
• SOB
• Muscle Spasms
• Dizziness/Vertigo
• Blurred Vision
• Headache
• Chest Pains
• Hyperthermia
• Tachypnea
• Palpitations
• Dry Mouth
• Nausea/Vomiting
• Hypertension
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Diagnosis of  BSA
• Suspect BSA if  previous signs are present, and 
history includes substance abuse
• Diagnosis of  relies on ruling out other possible 
causes of  signs and symptoms (differential 
diagnoses)
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Diagnosis of  BSA
• Standard drug screens cannot detect bath salts
• Although tests have been developed for the detection 
of MDPV and mephedrone, very few labs have them
• Tests are very expensive, and not available to most 
U.S. hospitals
• Physicians must rely on absence of  differential 
diagnoses to diagnose BSA
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Possible Differential 
Diagnoses
• Delirium
• Infection
• Psychiatric Illness
• Traumatic Brain Injury
• Electrolyte Imbalance
• Metabolic Disorders
• Endocrine Disorders
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Treatment of  BSA
• Largely supportive and guided by symptoms and 
complications 
• Assessment of  cardiac injury is imperative (troponin, CK)
• Benzodiazepines recommended for treatment of  psychotic 
symptoms
• N-Acetylcysteine has been used to minimize hepatic 
damage - further evaluation of indication needed
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Serious Complications of  BSA
• Excited Delirium
• “an agitated delirium with skeletal muscle damage 
proceeding in some cases to renal failure and death.” –
Penders et. al
• Delirium, severe agitation, and physiological excitation 
which develops over a short period of  time
• Associated with drug use and psychiatric illness
• Has been noted in cocaine use with fatal effects
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Slide 19 
Serious Complications of  BSA
• Compartment Syndrome
• Has been noted in at least three cases 
• One case of  compartment syndrome of  the back 
muscles which is extremely rare
• No apparent link to route of  administration
• No other precipitating factors
 
 
Slide 20 
Serious Complications of  BSA
• Necrotizing Fasciitis
• One case noted of  rapidly progressing necrotizing 
faciitis associated with IM injection
• Presented originally as cellulitis, rapidly deteriorated
• This patient lost her entire arm, and part of  her 
abdominal and chest wall
• A risk with all injectable drugs, often difficult to 
diagnose
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Serious Complications of  BSA
• Disseminated Intravascular Coagulation (DIC)
• At least four documented cases of  confirmed DIC 
resulting from bath salts abuse. 
• No apparent link to route of  administration
• Two cases resulted in death, confirmed by the medical 
examiner to be “death by toxic effects of  MDPV”
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Serious Complications of  BSA
• Rhabdomyolysis
• Breakdown of  muscle tissue releases myoglobin into blood, 
which is toxic to the kidneys
• Causes decreased urine output, dark red urine, general 
weakness, and muscle aching
• Serum creatine phosphokinase (CPK) level will be elevated
• Normal range: 10-120 mcg/L  
• Found in numerous case reports of  BSA. Some patients have 
recovered on dialysis, others have died
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Serious Complications of  BSA
• Persistent psychosis and hallucinations
• Last up to years after use, in some cases not yet resolved
• Some of  these users have been first-time users, while 
others had used the drug multiple times
• Electroconvulsive therapy used in one case, led to 
improvement
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Serious Complications of  BSA
• Multiorgan Failure
• Renal and hepatic failure noted in multiple case reports
• Respiratory failure has been reported
• Organ system failures may be due to hyperthermia (up 
to 109oF) and agitation, or the effects of  the drug itself
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Slide 25 
Nursing Implications of  BSA
• Continued education by nurses is vitally important 
to staying up to date on these drugs and others
• Bath salts are only one of  a multitude of  new “designer 
drugs” available to users that are not well known in 
healthcare
• Continuing education and research keeps nurses up to 
date on current risks and issues affecting their patients
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Nursing Implications of  BSA
• Ensure safety of  self  and staff
• These individuals can be highly aggressive and exhibit 
brute strength
• Security personnel whenever possible
• Very difficult, if  not impossible to “talk down” these 
individuals
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Nursing Implications of  BSA
• Thorough initial and ongoing assessment is key to the 
patient’s survival
• Evidence of  route of  administration
• Track marks, irritated nasal passages, needle marks
• Assess for cardiac, renal, hepatic, respiratory, musculoskeletal, 
and psychological complications
• Assess for changes in mental status and vital signs
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Nursing Implications of  BSA
• Be aware of  the patient’s risk for harm to self  and 
others
• One to one monitoring 
• Security personnel
• Restraints
 
 
Slide 29 
Nursing Implications of  BSA
• Obtain detailed history of  substance abuse from the 
patient/family
• History of  Bath Salts use
• History of  other drug use
• Were other drugs used simultaneously?
 
 
Slide 30 
Nursing Implications of  BSA
• If  restraints needed – reassess per protocol to 
minimize risk of  complications
• Due to musculoskeletal complications associated 
with excited delirium, restraints may increase risk 
of death in BSA patients
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Slide 31 
Nursing Implications of  BSA
• Patient education
• Educate about the dangers of  these drugs
• Educate about addictive properties and deadly 
complications
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Evaluation of Learning Questions for use by Clinical Educators 
 
1) What characteristics define the typical user of bath salts? 
 
2) What routes of administration are used for bath salts? 
 
3) What are the two most common synthetic cathinones found in bath salts? 
 
4) What are some psychological symptoms of bath salts intoxication? 
 
5) What are some physical symptoms of bath salts intoxication? 
 
6) What are possible serious complications of bath salt intoxication? 
 
7) How is bath salts intoxication treated? 
 
8) What is the most important consideration for nurses with regards to BSA? 
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Answers to Evaluation of Learning Questions 
1) Age 20-29  
Male 
History of substance abuse 
History of psychiatric illness 
 
2) IM/IV injection 
Insufflation 
Ingestion 
Rectal 
 
3) Mephedrone  
MDPV 
 
4) Delirium 
Hallucinations 
Paranoia 
Severe Agitation 
Combativeness 
Fear of nonexistent threats to self 
 
5) Hyperthermia 
Hypertension 
Tachycardia 
Tachypnea 
Sweating 
Shortness of Breath 
Dry Mouth 
Nausea/Vomiting 
Chest Pains/Palpitations 
Headache 
 
6) Cardiac injury 
Kidney injury 
Liver injury 
Compartment syndrome 
Necrotizing fasciitis 
DIC 
 
7) Treatment is supportive 
Benzodiazepines are recommended for psychotic symptoms 
 
8) The safety of self and staff! 
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